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The Transmembrane Molecule Kekkon 1 Acts in a
Feedback Loop to Negatively Regulate the Activity
of the Drosophila EGF Receptor during Oogenesis
roles, since quantitative variations in their level of activa-
tions can lead to very different cellular outcomes. For
example, studies in mammalian PC12 cells have illus-
trated that prolonged MAPK activation and nuclear
translocation triggers differentiation, whereas transient
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While many positive regulators/effectors of RTK sig-University of Colorado
naling activity have been characterized, only a few inhib-Boulder, Colorado 80309
itory molecules have been identified (Freeman et al.,
1992; Kharitonenkov et al., 1997). In addition to these
inhibitory molecules, a number of inhibitory mechanisms
Summary have been identified. These include internalization of
ligand±receptor complexes, receptor desensitization as
We have identified the Drosophila transmembrane a result of hyperphosphorylation of the receptor, in-
molecule kekkon 1 (kek1) as an inhibitor of the epider- hibitory regulation by cytoplasmic and transmembrane
mal growth factor receptor (EGFR) and demonstrate protein phosphatases, and targeting to the proteolytic
that it acts in a negative feedback loop to modulate the pathway of specific signal transducers (Ullrich and
activity of the EGFR tyrosine kinase. During oogenesis, Schlessinger, 1990; Sturtevant et al., 1994; van der Geer
kek1 is expressed in response to the Gurken/EGFR et al., 1994; Kokel et al., 1998). By integrating particular
signaling pathway, and loss of kek1 activity is associ- stimulatory and inhibitory mechanisms in cells, RTK ac-
ated with an increase in EGFR signaling. Consistent tivities can be quantitatively regulated to direct distinct
with our loss-of-function studies, we demonstrate that cellular outcomes.
ectopic overexpression of kek1 mimics a loss of EGFR The Drosophila EGFR is required for a multitude of
activity. We show that the extracellular and transmem- developmental processes throughout the life cycle (re-
brane domains of Kek1 can inhibit and physically asso- views by Ray and Schupbach, 1996; Perrimon and Per-
ciate with the EGFR, suggesting potential models for kins, 1997; Schweitzer and Shilo, 1997). For example,
this inhibitory mechanism. activation of the EGFR pathway in follicle cells during
oogenesis establishes both anteroposterior and dorso-
ventral fates. During embryogenesis, the EGFR is required
Introduction for the establishment of ventral cell fates, determination
of segmental identity, maintenance of amnioserosa and
The biological processes regulated by receptor tyrosine ventral neuroectodermal cells, germband retraction, cell
kinase (RTK) signaling pathways are diverse and include fate specification in the central nervous system, and
the regulation of cell growth, differentiation, migration, production of cuticle. During larval development, the
viability, and maintenance of homeostasis (see review EGFR plays a role in cell proliferation, vein formation,
by Ullrich and Schlessinger, 1990). In the past few years, and eye development. These multiple tissue-specific ac-
a great deal has been learned about the mechanisms tivities are regulated in part by different ligands that con-
by which RTKs transduce signals and specify particular tain an EGF repeat similar to that of transforming growth
cellular fates. In particular, most RTKs have been shown factor a (TGFa), a known ligand of the vertebrate EGFR.
to regulate gene expression through the Ras/Raf/MEK/ To date, three such ligands have been isolated in Dro-
MAPK cassette (see Li and Perrimon, 1997). Although sophila: Spitz (Spi; Rutledge et al., 1992; Schweitzer et
the pathways that transduce signals from RTKs to the al., 1995a), Gurken (Grk; Neuman-Silberberg and Schup-
nucleus have been well characterized, less is known bach, 1993), and Vein (Vn; Schnepp et al., 1996). In con-
about the mechanisms involved in imparting specificity. trast to these stimulatory molecules, Argos (Aos), a se-
More recently, however, it has been shown that modula- creted protein with an atypical EGF motif, has been
shown to act as an antagonist of EGFR activity (Schweitzertion of RTK activities is a critical aspect of their biological
et al., 1995b). In vitro studies have revealed that Aos
can interfere with EGFR activation in a manner that is
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rascal.med.harvard.edu [N. P.], jduffy@bio.indiana.edu [J. B. D.]).
posed that Aos acts as a direct inhibitor of Spi by binding6 Present address: deCode Genetics, Lynghals 1, 110 Reykjavik,
directly to the EGFR (Schweitzer et al., 1995b). Remark-Iceland.
ably, the expression of aos is dependent upon EGFR7 Present address: Department of Biology, Indiana University, Jordan
Hall, Bloomington, Indiana 47405. activation (Golembo et al., 1996b), thus demonstrating
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that the EGFR regulates the expression of its own nega-
tive regulator.
During late oogenesis, EGFR activity is regulated by all
of these mechanisms, and its precise activity is critical in
specifying the proper pattern of the chorion and embryo
(review by Ray and Schupbach, 1996). Thus, function
of the EGFR during oogenesis provides an excellent
paradigm to characterize the quantitative regulation of
the EGFR and determine if additional components of
this pathway exist. In response to Grk signaling from
the oocyte, activation of the EGFR in follicle cells follows
a dynamic pattern. In early egg chambers, Grk first acti-
vates the EGFR pathway in posterior follicle cells. Sub-
sequently, around stage 7, grk transcripts become local-
ized to the anterodorsal corner of the oocyte and signal
to adjacent follicle cells to define their dorsal fates. Acti-
vated EGFR molecules regulate transcription through
the Ras/Raf/MEK/MAPK cassette in follicle cells (Brand
and Perrimon, 1994; Hsu and Perrimon, 1994; Schnorr
and Berg, 1996). In a screen to identify downstream
genes regulated by the EGFR in follicle cells, we have
identified the gene kekkon 1 (kek1), which encodes a
single pass transmembrane protein with features of a
cell adhesion molecule with leucine-rich repeats (LRR)
and immunoglobulin (Ig) motifs (Musacchio and Perri-
mon, 1996), as a target gene. We demonstrate that en-
dogenous kek1 acts in an inhibitory manner: loss of kek1 Figure 1. kek1 Is a Transcriptional Target of the EGFR Pathway
activity results in increased EGFR signaling. We also (A±C) Expression of kek1 in the follicle cells revealed by the kek-lacZ
enhancer trap insertion. kek-lacZ expression can first be detected indemonstrate that overexpression of kek1 blocks the ac-
region 2 of the germarium (A). Expression continues to be detectedtivity of the EGFR. This inhibition involves a physical
at the poles of stage 1±6 egg chambers. Following the dorsal±association between the extracellular and transmem-
anterior migration of the oocyte nucleus, kek-lacZ expression under-
brane domains of Kek1 with the EGFR. This establishes goes a similar shift to a dorsal±anterior region of the follicular epithe-
Kek1 as a bona fide inhibitor of the EGFR that acts in lium in stage 8 and 9 egg chambers (B). The position of the oocyte
a negative feedback loop to modulate the activity of this nucleus is marked by the arrow. A lateral view of a stage 10 egg
chamber showing the dorsal±anterior graded expression of kek-RTK signaling pathway.
lacZ(C).
(D±F) kek-lacZ expression is under the control of the EGFR signaling
pathway. In females homozygous for the hypomorphic Draf muta-
Results tion, DrafHM7 (Melnick et al., 1993) kek-lacZ expression is severely
reduced (D). Expression of kek-lacZ is completely abolished in ova-
kek1 Is Regulated by the Grk/EGFR Pathway ries of females homozygous for grkHK36 (E) or mutations in the egfr
associated with female sterility (data not shown). Ectopic activationin Follicle Cells
of the EGFR receptor pathway using the gain-of-function Draf geneTo characterize target genes of the EGFR signaling path-
hsDrafgof-F22 (F) leads to uniform kek-lacZ expression. Induction ofway, we screened a collection of enhancer trap lines for
WT Draf during oogenesis had no effect on the expression of kek-
expression patterns in follicle cells. We found one line, lacZ (not shown).
15A6, which was expressed in a pattern consistent with (G and H) The position of the oocyte nucleus defines the spatial
it being a regulatory target of the EGFR pathway, since domain of kek1 expression. In response to colchicine treatment, the
oocyte nucleus and its associated grk mRNAs become misplacedit undergoes a transition during stages 8±10 when it
during oogenesis (G and H). In these egg chambers, the expressionrelocalizes from a posterior to a dorsal±anterior gradient
of kek-lacZ can be detected posteriorly as well as ventrally. In (G)(Figures 1A±1C). 15A6 corresponds to an insertion in
and (H), the germline nuclei are marked with the enhancer trap line
the kek1 gene (Musacchio and Perrimon, 1996), and we es(3)79 to allow easy detection of the oocyte nucleus (indicated by
refer to it as kek-lacZ in the text. We found that kek- the arrows).
lacZ expression reflects accurately the expression of (C±H) are stage 10 egg chambers oriented with dorsal up. Anterior
is to the left in all panels.kek1 both in wild-type (WT) and in mutant backgrounds
(data not shown).
To establish a regulatory link between the transcrip- et al., 1997; Sapir et al., 1998), revealing that kek-lacZ
tional regulation of kek1 in the follicle cell epithelium expression is transcriptionally regulated by the Grk/
and the Grk/EGFR signaling pathway, we examined kek- EGFR/Draf pathway. Expression of an activated form of
lacZ expression in mutants for grk, egfr, and the kinase Draf resulted in the ubiquitous expression of kek-lacZ
Draf that is both necessary and sufficient for EGFR sig- within the follicular epithelium (Figure 1F).
naling in follicle cells (Brand and Perrimon, 1994). In To further analyze the role of the Grk/EGFR pathway
each case, the dorsal±anterior gradient of kek-lacZ ex- in the transcriptional control of kek-lacZ, we mislocal-
pression was abolished or severely diminished (Figures ized the subcellular localization of grk mRNAs by dis-
rupting the oocyte cytoskeletal network (Figure 1G).1D and 1E; see also Brand and Perrimon, 1994; Queenan
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Figure 2. Overexpression of kek1 during Oo-
genesis Blocks the Activity of the EGFR
Phenotypes of eggs and embryos derived
from WT (A), T155; UAS-kek1 (B), and T155;
UAS-egfrDN (C) females. The eggshell is se-
creted by the follicle cells during oogenesis.
Specialized groups of follicle cells on the dor-
sal side of the egg chamber form the two
dorsal respiratory appendages. Note that the
chorionic filaments, localized anteriorly in the
WT, are fused, do not elongate, and are posi-
tioned more posteriorly when either kek1 or
the egfrDN is expressed uniformly in follicle
cells using the Gal4 driver T155. The embry-
onic cuticles that develop from these eggs
are strongly ventralized (cf. Figures B2 and
C2 with the WT in Figure A2), as observed in
embryos derived from grk homozygous
mothers (Roth and Schupbach, 1994). This
ventralization phenotype can be readily de-
tected using the Twi marker for ventral cell
fates. In WT embryos (A3 and A4), Twi is ex-
pressed in the ventral-most region of the em-
bryo. The Twi expression domain is enlarged
when either kek1 or the egfrDN is misex-
pressed (B3, B4, C3, C4).
In all panels, anterior is to the left. The chorions shown in (A1), (B1), and (C1) are dorsal views. The embryos in (A2), (B2), (C2), (A3), (B3), (C3),
and (A4), (B4), and (C4) are lateral and ventral views, respectively.
Treatment of the oocyte with colchicine, an inhibitor of In addition to its role in establishing the dorsal charac-
teristics of the eggshell, the Grk/EGFR pathway controlsmicrotubule polymerization, leads to mislocalization of
the oocyte nucleus and its associated grk mRNAs, which embryonic dorsoventral patterning by restricting a ven-
tralizing signal (Neuman-Silberberg and Schupbach,correlated with ectopic kek-lacZ expression (Figure 1H)
as well as kek1 mRNA expression (not shown). Alto- 1994; Morisato and Anderson, 1995). As a result, loss of
EGFR function leads to ventralized embryos. Embryonicgether, these results demonstrate that Grk is not only
necessary but sufficient to regulate the spatial expres- cuticles derived from T155; UAS-kek1 females showed
a ventralized cuticle phenotype (Figure 2B2). To analyzesion of kek1.
the extent of this ventralization, we stained embryos for
Twist (Twi) RNA and protein that label a ventral domainOverexpression of kek1 during Oogenesis
Antagonizes EGFR Activity ten cells wide (Thisse et al., 1988). Overexpression of
kek1 in follicle cells results in an expansion of the TwiPrevious analysis has revealed that in the complete ab-
sence of kek1 gene activity, flies are viable, fertile, and expression domain (Figures 2B3 and 2B4). Similarly, em-
bryos derived from T155; UAS-egfrDN females are alsodo not exhibit any overt morphological defects (Musac-
chio and Perrimon, 1996). Kek1 has the features of cell strongly ventralized (Figures 2C2±2C4).
Altogether, our results indicate that overexpressionadhesion molecules (CAMs), and loss-of-function muta-
tions of many CAMs have subtle mutant phenotypes. of kek1 in follicle cells ventralizes both the eggshell and
the embryo by most likely interfering with the activity ofHowever, when ectopically overexpressed, some CAM
molecules can generate striking mutant phenotypes that the Grk/EGFR signaling pathway.
are revealing of their functions (Speicher et al., 1998).
Thus, to gain insights into the possible function of kek1 Kek1 Inhibits the Activity of
the Ras/Raf/MEK/MAPK Cassetteduring oogenesis, we tested the effect of overexpress-
ing kek1 in the follicle cells using the GAL4/UAS system To determine whether Kek1 blocks the signaling activity
of the EGFR, we tested whether ectopic expression of(Brand and Perrimon, 1993).
When kek1 is expressed under the control of the GAL4 kek1 blocks the transcriptional activation of target genes
regulated by the EGFR/Ras/Raf/MEK/MAPK pathway inline T155, which drives expression all over the follicle
cell epithelium beginning at stage 9 (Harrison et al., 1995; follicle cells. Since kek1 is a target of this pathway, we
used kek-lacZ as a reporter for this experiment. Overex-Queenan et al., 1997), 100% of the resulting eggs are
longer than the WT eggs and have a reduction or a pression of kek1 using the Gal4 driver T155 was associ-
ated with a strong but not complete reduction of kek-complete loss of dorsal appendages (cf. Figure 2B1 with
the WT in Figure 2A1). This loss of dorsal appendage lacZ expression (cf. Figure 3B to WT in Figure 3A). Using
a stronger Gal4 line, CY2 (Queenan et al., 1997), a com-material is due to a ventralization of the eggshell, a
phenotype associated with egfr, or grk loss-of-function plete disappearance of kek-lacZ expression was ob-
served (Figure 3C). These data are consistent with themutations (Schupbach, 1987; Price et al., 1989). A similar
ventralized eggshell phenotype was obtained when a model that Kek1 downregulates the activity of the Ras/
Raf/MEK/MAPK pathway. Consistent with this, epistasisdominant-negative form of the EGFR, EGFRDN, was
expressed under the control of T155 (Figure 2C1). experiments indicate that the inhibitory effect of Kek1
Cell
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ventralization phenotype of UAS-kek1 (Figure 4), indicat-
ing that Kek1 can block the effect of Rho on EGFR
activation. Altogether, these results place Kek1 up-
stream of the EGFR and downstream of Rho.
The Extracellular Domain of Kek1 Is Critical
for the Inhibitory Effect
To test whether the extracellular domain of Kek1, which
contains five LRR and one Ig motif (Musacchio and Perri-
mon, 1996), is required for the inhibition of the EGFR
activity by Kek1, we generated transgenic lines that con-
tain either UAS-kek1extra or UAS-kek1intra.
No phenotype were observed by overexpressing
kek1intra (data not shown) in the follicle cells using the
T155 or CY2 GAL4 lines. On the other hand, overexpres-
sion of kek1extra using the same drivers led to eggs with
reduced dorsal appendage materials (Figure 5A) and
ventralized embryos (Figures 5B and 5C). These obser-Figure 3. Kek1 Inhibits the Activity of the Ras/Raf/MEK/MAPK Cas-
vations indicate that the extracellular domain of Kek1sette
is sufficient to inhibit the activity of the EGFR.Expression of kek-lacZ in WT (A) and following ectopic overexpres-
sion of kek1 in the follicular cell epithelium using either the T155 (B) Although the phenotypes obtained following kek1extra
or CY2 Gal4 (C) drivers. Only the most dorsal anterior patch of overexpression are very similar to those obtained with
follicle cells at stage 10 are still expressing kek-lacZ in (B), while full-length kek1, we note that these phenotypes are
the expression of the reporter gene is completely absent in (C). The weaker. One possibility is that Kek1extra is expressed at
genotypes of the egg chambers shown in (B) and (C) are UAS-
a lower level than the WT protein. Weaker effects werekek1/kek-lacZ; T155 and UAS-kek1; kek-lacZ/CY2, respectively.
observed with 12 independent transgenic lines, as wellAll panels are dorsal views of stage 10 egg chambers stained with
X-Gal. as when multiple copies of the transgenes were added.
This suggests that Kek1extra is less stable than the full-
length Kek1 molecule or that the cytoplasmic domain
is overridden by the constitutive activation of the EGFR of Kek1 participates to some extent in the inhibition.
or Draf (Figure 4). In addition, we tested the interaction Finally, we tested whether the inhibition of the EGFR
between the transmembrane protein Rhomboid (Rho) activity by kek1extra requires the presence of the endoge-
and Kek1. Rho has been proposed to play a role in nous Kek1 protein. When kek1extra was overexpressed
the activation of the EGFR (Schweitzer et al., 1995a; in kek1 mutant females, the eggs were ventralized, which
Golembo et al., 1996a), and overexpression of Rho leads excludes a model whereby kek1extra blocks the EGFR
to dorsalized eggshells (Ruohola-Baker et al., 1993). We by forming a heterodimer with the endogenous Kek1
protein (data not shown).find that overexpression of rho does not override the
Figure 4. Genetic Epistasis between Kek1,
Rho, and Constitutively Activated Forms of
Either D-Raf or the EGFR (lTop)
(A) Chorion phenotypes. (1) Eggs derived
from UAS-Kek1; UAS-Rho/T155 females are
strongly ventralized. (2) Eggs derived from
UAS-Kek1; UAS-ltop/T155 females are dor-
salized and are similar to those laid by UAS-
ltop/T155 females. Dorsalization is clearly
visible by the extraappendage materials de-
posited around the entire egg circumference.
(B) Summary table of the various genotypes
analyzed.
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only one copy of P[grk] lay WT eggs (Neuman-Silberberg
and Schupbach, 1994; this study, data not shown). We
found that eggs laid by females carrying one copy of
P[grk] in the absence of kek1 are significantly dorsalized
(Figure 6B1): the spacing between the dorsal append-
ages is increased and the eggs are rounder and smaller.
Further, Twi expression that is normally expressed in
embryos laid by females carrying one copy of P[grk]
(n 5 168; data not shown) is repressed ventrally in 15%
(n 5 181) of the embryos derived from kek1 mutant
females that carry a single copy of P[grk]. When raised
at 298C, 22% (n 5 348) of the embryos derived from
eggs laid by females carrying one copy of P[grk] in the
absence of kek1 showed a dorsalized phenotype readily
detectable by aberrant Twi expression. We note that
there is a variability in the reduction of the Twi domain,
ranging from embryos in which Twi-expressing cells are
missing in the middle regions of the embryo to the most
severe cases in which only the poles express the Twi
protein (Figures 6B2 and 6B3).
Figure 5. The Extracellular Domain of Kek1 Is Sufficient to Inhibit
Second, we reasoned that if loss of Kek1 activity leadsthe Activity of the EGFR
to a hyperactivation of EGFR activity, then loss of Kek1Eggs derived from CY2; UAS-kek1extra females that express kek1extra
activity should rescue a decrease in EGFR activity. Wein follicle cells using the Gal4 line CY2 exhibit a ventralized eggshell
tested this hypothesis by generating flies that simulta-phenotype (A). Consistently, the embryos that develop from these
eggs show a ventralized cuticle phenotype (B) and a lateral expan- neously lacked Kek1 activity and had reduced activity
sion of Twi expression (C). (A) is a dorsal view, and (B) and (C) are of the EGFR. Consistent with our hypothesis, loss of
lateral views. Kek1 activity resulted in partial suppression of the EGFR
phenotype (Figures 6C1±6C3). Eggs laid by females mu-
tant for EGFR alone have a ventralized phenotype
Kek1 Is a Negative Regulator of the Grk/EGFR (Schupbach, 1987). They exhibit either no or only a single
Signaling Pathway dorsal appendage, and the eggs are significantly longer
Because of the severe inhibition of EGFR activity by than WT (100%, n 5 852; Figures 6C1 and 6C2). In
Kek1 revealed by the overexpression experiment, we contrast, the majority of eggs (95.5%, n 5 1103) laid by
decided to reexamine the effect of loss of kek1 function the kek12 egfr2 double mutant females have two dorsal
during oogenesis. We reasoned that a subtle egg mor- appendages and their length is shorter, consistent with
phology phenotype may have been missed by simply a reversion to a more WT phenotype (Figure 6C3).
using fertility as an assay (Musacchio and Perrimon,
1996). Indeed, we found that the spacing between the Kek1 Physically Associates with the EGFR
dorsal appendages of eggs derived from kek1 mutant Having demonstrated that the in vivo role of kek1 is
females was increased when compared to WT. Further, consistent with the results obtained by overexpression,
these eggs were also mildly shorter and rounder (Figure we wanted to gain insight into the mechanism of inhibi-
6A1), a phenotype consistent with a hyperactivation of tion of the EGFR by Kek1. To do so, we tested whether
the Grk/EGFR pathway (Neuman-Silberberg and Schup- EGFR and Kek1 physically associate. Following coex-
bach, 1994). These features do not interfere with hatch- pression of a Myc-tagged version of Kek1 and the EGFR
ing rates and patterning that is consistent with the nor- or the Drosophila Torso RTK in Sf9 cells, Kek1 was
mal Twi expression found in kek1 mutant embryos (n 5 immunoprecipitated from the cell lysates using an anti-
142). Interestingly, when kek1 mutant flies were raised Myc antibody. Coprecipitation of the EGFR was ob-
at 298C, 5% (n 5 257) of the embryos derived from served by probing the resulting blot with the anti-EGFR
kek1 mutant females showed a mild reduction in Twi antibody (Figure 7A), suggesting that Kek1 associates
expression (Figures 6A2 and 6A3). We conclude that physically with the EGFR and that this interaction is
loss of kek1 activity during oogenesis leads to mildly responsible for the inhibitory effect. When both Kek1
dorsalized eggs. and Torso were coexpressed in Sf9 cells, no Torso was
To substantiate the functional relationship between coprecipitated by Kek1 (Figure 7A), suggesting a selec-
Kek1 and the Grk/EGFR signaling pathway during oo- tivity of Kek1 for binding to the EGFR.
genesis, we examined the effects of a loss of Kek1 Because the extracellular and transmembrane por-
activity in two different genetic backgrounds. First we tions of Kek1 are essential for the inhibitory effect, we
tested if an increase in the level of Grk molecules can examined whether these portions of Kek1 are able to
generate a stronger phenotype in the absence of kek1. bind to the EGFR. As shown in Figure 7B, the extracellu-
Previously, Neuman-Silberberg and Schupbach (1994) lar domain, but not the intracellular domain, of Kek1 can
showed that females carrying four copies of a transgene bind to the EGFR. Thus, we propose that the inhibitory
expressing grk (P[grk]), in addition to the two endoge- effect of the EGFR by Kek1 is mediated through direct
nous copies, lay a significant fraction of partially or se- association of the extracellular and transmembrane do-
mains of Kek1 with the EGFR.verely dorsalized eggs. In contrast, females that carry
Cell
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Figure 6. Phenotypes Associated with Loss of kek1 Function during Oogenesis
(A1±A3) At 258C, eggs derived from kek1 mutant females showed a weak dorsalization phenotype that does not interfere with fertility. This
dorsalization phenotype is evident by the more lateral position of the dorsal appendages (cf. Figure 6A1 with a WT eggshell shown in Figure
2A1). By increasing the temperature, we observed a weak enhancement of both the eggshell and the embryonic phenotypes readily detectable
by aberrant Twi expression (Figures 6A2 and 6A3).
(B1±B3) The dorsalization phenotype associated with loss of kek1 function is enhanced by an increase in the level of Grk ligand. The eggs
derived from kek1 mutant females that contain an extra copy of grk, provided by a P[grk] transgene, showed an enhancement of the dorsalized
eggshell phenotype (cf. Figure 6B1 with Figure 6A1), and the embryos derived from these eggs showed a stronger dorsalized phenotype (cf.
Figures 6B2 and 6B3 with Figures 6A2 and 6A3). Orientations are the same as in Figure 2.
(C1±C3) Suppression of the egg phenotype associated with egfr mutations by kek1. Chorions derived from egfr2 or kek12 egfr2 females are
shown. (C1) egfrQY1/egfr2E07. (C2) egfrQY1/kek1RM2 egfr2E07. (C3) kek1RA5 egfrQY1/kek1RM2 egfr2E07. In addition to the recovery of the two dorsal
appendages, the length of the chorion has also become similar in length to WT.
Discussion The Function of Kek1 in Patterning of the Follicle
Cell Epithelium
During oogenesis, Grk derived from the oocyte activatesWe have identified the transmembrane protein Kek1 as
in a paracrine fashion the EGFR in dorsal follicle cells.a molecule that acts in a negative feedback loop to
Recent work from Wasserman and Freeman (1998) hasmodulate the activity of the Drosophila EGFR tyrosine
shown that this paracrine signaling leads to the activa-kinase during oogenesis. We provide loss-of-function,
tion of a second phase of signaling, whereby the EGFRectopic overexpression, and biochemical evidence to
activity is amplified among follicle cells themselves. Dur-support this. First, eggs laid by females that lack kek1
ing this second phase, the EGFR activates a number ofgene activity are weakly dorsalized, and loss of kek1
target genes that include both positive (rho and vn) andgene activity can suppress egfr mutations and potenti-
negative (aos) regulators of the pathway. Activation ofate Grk signaling. Second, ectopic overexpression of
Rho in follicle cells presumably leads to the activationKek1 in follicle cells leads to severe ventralization identi-
of the Spi EGFR ligand, while activation of Aos withincal to effects seen in EGFR mutants, providing further
the peak of EGFR activity at the dorsal anterior leadssupport of Kek1 as a negative regulator of the EGFR
to repression of EGFR, effectively splitting the initialpathway. Finally, we provide biochemical evidence that
peak of EGFR activity into two. This splitting of EGFR
the inhibition of EGFR activity by Kek1 involves the direct
activity eventually defines the domains where the dorsal
association between the extracellular and transmem- appendages will form.
brane domains of Kek1 and the EGFR. Our identification of Kek1, together with the studies
Interestingly, kek1 is expressed in the eye and wing on Aos, indicates that there are at least two different
imaginal discs in a pattern that is highly suggestive of negative regulators of EGFR activity in follicle cells.
induction by the EGFR (Musacchio and Perrimon, 1996). However, the regulation and function of Kek1 is distinct
Although no obvious phenotypes have been described from those of Aos. aos is expressed only in response
in these tissues in kek1 mutants, we found that overex- to high levels of EGFR activity, while kek1 is expressed
pression of kek1 in these tissues also generate pheno- in a graded fashion. Further, loss-of-function pheno-
types reminiscent to loss of EGFR activity (not shown). types of kek1 and aos in follicle cells are different. In
This suggests that the negative regulation of the EGFR the absence of kek1 activity, the spacing between the
dorsal appendages is increased, while in the absenceby Kek1 is not only restricted to oogenesis.
A Novel Regulator of the Drosophila EGF Receptor
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Further, we have shown that the extracellular and trans-
membrane domains of Kek1 are sufficient for this inhibi-
tion. The extracellular domain of Kek1 contains one Ig-
like domain and five LRRs, both of which can mediate
protein±protein interactions (Musacchio and Perrimon,
1996). A number of mechanisms can underlie the mecha-
nism by which this extracellular domain acts as an inhibi-
tor. For example, the Kek1 extracellular domain could
mask the accessibility of the extracellular domain of
the EGFR to all ligands. Conversely, it could form
a heterodimer with EGFR monomers and block their
dimerization. Dimerization is a prerequisite to the ac-
tivation of downstream signaling events by the RTK.
Alternatively, Kek1 could be involved in bringing a trans-
membrane tyrosine phosphatase to the vicinity of the
EGFR and thus lead to its deactivation. Consistent with
these models, we have observed that Kek1 can inhibit
mammalian EGFR molecules from becoming tyrosine
phosphorylated in response to growth factor treatment
in infected insect cells (L. T. A. et al., unpublished obser-
vations). Finally, we envision that Kek1 could target the
EGFR to a degradation pathway through endocytosis
or bind to additional proteins involved in their subcellular
localization. Studies on the C. elegans LET-23 EGFR
have well illustrated the critical role of subcellular local-
ization and PDZ proteins in signaling by this RTK (Kim,
1997; Kaech et al., 1998). Interestingly, we note that
both Kek1 and the EGFR contain a TXV motif at the
C terminus. This S/TXV motif has been implicated in
protein±protein interactions and suggests that Kek1
Figure 7. Association of Kek1 with the Drosophila EGFR and/or the EGFR may interact with PDZ-containing pro-
(A) Lysates from Sf9 insect cells expressing the Drosophila EGFR teins (Songyang et al., 1997; see reviews by Kim, 1997
or Torso, or Kek1-Myc (kek) alone, or coexpressing Kek1-Myc with and Ponting et al., 1997). Consistent with this, our analy-
each of the RTKs were immunoprecipitated with anti-Myc antibod-
sis of the Kek1 molecule has led us to conclude thaties. Precipitates were immunoblotted with anti-EGFR (upper left
Kek1extra is less stable than the full Kek1 molecule or thatpanel) or anti-Torso (upper right panel) and reprobed with anti-Myc
the cytoplasmic domain of Kek1 participates to some(lower panels). In Sf9 cells, the EGFR migrates at two prominent
forms. The lower EGFR band probably represents an underglycosy- extent in the inhibition. Possibly, Kek1 is targeted to a
lated form of the receptor. We noted that at higher Kek1 expression subcellular region within the cells where the EGFR itself
levels binding to Torso was also observed (not shown), perhaps is located. This model would explain why unlocalized
reflecting some degree of stickiness of the Kek1 protein.
Kek1extra would be less efficient at inhibiting EGFR activ-(B) Sf9 cells were infected with baculovirus encoding the Drosophila
ity than the full-length Kek1 molecule.EGFR and coinfected with nothing (None) or viruses encoding Myc-
tagged versions of full-length Kek1 (kek), a form encompassing the
transmembrane and the extracellular domains of Kek1 (kek ECD), An Emerging Theme in Patterning Mechanisms
and a form encoding the intracellular domain of Kek1 fused to a Kek1 identifies a novel member of a growing class of
v-Src myristylation site (kek ICD). Anti-Myc immunoprecipitates
negative regulators that are positively transcriptionallywere blotted with anti-EGFR (left panel) and then reprobed with
regulated by the pathway that they inhibit. As discussedanti-Myc (right panel). Note that the 55 kDa Kek1 intracellular domain
in the Introduction, the secreted molecule Aos acts inis hidden in the Myc immunoprecipitate by the heavy chain of the
precipitating antibody, but it has been detected in the lysates. a feedback loop to downregulate in a paracrine fashion
the activity of the EGFR, possibly by preventing the
mechanism of activation of the receptor by the Spi ligand
(Schweitzer et al., 1995b; Golembo et al., 1996b). An-of aos, the appendages are fused dorsally. Aos has been
other inhibitor of an RTK pathway is Sprouty, whichproposed to split the initial peak of EGFR activity into
antagonizes the activity of the FGF receptor Breathlesstwo (Wasserman and Freeman, 1998). We propose that
(Btl) and is transcriptionally controlled by activated Btlthe function of Kek1 is to restrict the lateral spreading
(Hacohen et al., 1998).of EGFR activation by Spi. Thus, in the absence of kek1
It is worth noting, however, that not all secreted nega-activity, Rho/Spi activation could spread more laterally,
tive regulators of specific signaling pathways work inexplaining the enhancement of the spacing between the
negative feedback loops. These include Chordin/SOGtwo dorsal appendages.
(Piccolo et al., 1997) and Noggin (Zimmerman et al.,
1996), which antagonize signaling by TGF-b family mem-
bers; FrzB proteins, which encode secreted proteinsMechanism of Inhibition of the EGFR by Kek1
Our analysis demonstrates that Kek1 acts as a potent with sequence homologies to the extracellular cysteine-
rich domain of Frizzled transmembrane receptors, actnegative regulator of EGFR activity when overexpressed.
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The hypomorphic Draf mutation DrafHM7 is described in Melnick etas inhibitors of secreted Wnt ligands (Leyns et al., 1997;
al. (1993). hs-Drafgof-F22 that expresses an N-terminal truncation ofWang et al., 1997). Finally, not all negative regulators that
Draf is described in Brand and Perrimon (1994). The UAS-EGFRDNact in feedback loops act extracellularly. For example,
is described in Freeman (1996). The enhancer trap line es(3)79, the
Smad7, which is expressed in response to TGF-b signal- P[grk], and the UAS-ltop (Queenan et al., 1997) flies were a gift
ing, blocks the activity of this pathway intracellularly by from T. Schupbach.
Ectopic expression in the follicular epithelium was performed withbinding to the TGF-b receptor and by inhibiting Smad2
the pGawB GAL4 lines T155 (Harrison et al., 1995) and CY2 (Queenanand Smad3 phosphorylation that is required for trans-
et al., 1997).duction of the signal (Nakao et al., 1997). Another exam-
ple is the human CL100 phosphatase that after being
Inhibitor Studiesexpressed following exposure to either oxidative stress
The colchicine inhibitor was used at 25 or 50 mg/ml to destabilizeor heat shock downregulates specifically the MAP ki-
microtubules as described in Theurkauf et al. (1993). As a control,
nase (Keyse and Emslie, 1992). The Drosophila homolog flies were treated with 50 mg/ml of b-lumicolchicine, which is an
of CL100, known as puckered, has been shown to medi- inactive isomer of colchicine. After initiating treatment, flies were
ate a feedback loop regulating JNK activity during dorsal dissected and fixed at 4, 8, 10, and 24 hr intervals over 48 hr and
probed for expression of grk mRNAs. Stage 10 chambers treatedclosure in Drosophila (Martin-Blanco et al., 1998).
after the dorsal±anterior migration of the oocyte nucleus showed a
higher frequency of disrupted and irregular kek-lacZ expression (49/
Kek1 Defines a Novel Gene Family 156) than chambers treated prior to the migration (17/108). Earlier
In Drosophila, two other putative Kek molecules that treated chambers had a higher frequency of posteriorly shifted gra-
share extensive homologies with kek1 have been identi- dients (88/108 early versus 31/156 late). Finally, we detected no
effects with cytochalasin D, an inhibitor of microfilaments.fied: kek2 (Musacchio and Perrimon, 1996) and kek3
(our unpublished data). The function of these additional
In Situ Hybridization and b-Galactosidase HistochemistryKek-like proteins is not known. However, it is interesting
In situ hybridization was performed with digoxigenin-labeled grk,to note that despite extensive saturation of the region
kek1, and twist RNA essentially as described in Tautz and Pfeiflecontaining kek3, no mutant alleles have been recovered
(1989) using 558C and 658C as the hybridization temperature.(Ashburner et al., 1990; Spradling et al., 1995; our unpub-
For detection of b-galactosidase activity, ovaries were dissected
lished data). Whether or not this and the subtle effect in PBT (PBS 1 0.1% Tween 20) and fixed in 4% methanol-free
of loss of Kek1 activity is due to redundancy within the formaldehyde for 15 min or in 2.5% glutaradehyde for 2.5 min. Ova-
ries were then stained with 1 mg/ml X-Gal in X-Gal staining bufferKekkon family remains to be determined. Thus, it will
at 258C for 3.5±4.5 hr.be important to characterize the expression patterns as
The polyclonal rabbit anti-Twist antibody (Roth et al., 1989) waswell as the loss-of-function and overexpresssion pheno-
used at a dilution of 1:5000.types of kek2 and kek3 in order to evaluate any potential
For visualization, embryos and egg chambers were directly
abilities to modulate the EGFR activity. Further, chimeric mounted in 80% glycerol and photographed under Nomarski optics
proteins between these molecules may help to further with a Zeiss Axiophot microscope. Embryonic cuticles and chorions
were prepared according to van der Meer (1977) and visualizeddefine the Kek1 domain(s) required for the inhibitory
using dark-field optics.mechanism.
Finally, we note that there are putative transmem-
Constructsbrane proteins in vertebrates (Suzuki et al., 1996) and
UAS-kek1 was made in the following manner. A HindIII/EcoRI frag-invertebrates that show similar arrangements of LRRs
ment from the kek1 cDNA containing the complete coding regionand Ig motifs. This raises the possibility that Kek1 is a
(Musacchio and Perrimon, 1996) was subcloned into pBSK1. From
member of a family of structurally related EGFR inhibi- this subclone, an XbaI/XhoI fragment containing the complete kek1
tors. As alteration in the activity of the various members coding region was cloned into the P element vector pUAST (Brand
of the human EGFR/ErbB family has strong links to on- and Perrimon, 1993). UAS-kek1extra was made by inserting by PCR
a stop codon immediately after the transmembrane domain of kek1cogenesis, it will be important to determine if vertebrate
and UAS kek1intra by fusing a v-Src myristylation site to the entireLRR/Ig molecules share functional, in addition to se-
intracellular domain of kek1. P element±mediated transformationquence, similarities to Kek1. We anticipate that the con-
was performed following injection into the delta 2±3 transposase
tinued characterization of the Kek and related molecules strain (Robertson et al., 1988).
will provide novel approaches to the design of inhibitors
of the EGFR/ErbB family for therapeutic use in onco-
Insect Cell Experiments
genesis. cDNAs encoding the Drosophila EGFR and myc-tagged versions
at the C terminus of full-length kek1, kek1extra, and kek1intra were
subcloned into the baculovirus transfer vectors pVL1392 or pVL1393Experimental Procedures
(Pharmingen).
Recombinant baculoviruses were produced in Sf9 insect cellsFly Stocks
Various collections of enhancer trap lines were screened for expres- using the Bac-N-Blue transfection kit (Invitrogen) and plaque puri-
fied prior to use. For coexpression experiments, 107 Sf9 cells weresion patterns within the follicular epithelium (Perrimon et al., 1991;
Smith et al., 1993; D. Eberl, unpublished). From this screen, the infected at a multiplicity of infection of 30. For the EGFR/Torso
comparison experiment, cells were infected with a 1:1:28 ratio ofsecond chromosomal enhancer trap line 15A6 was identified. For a
description of 15A6, which we refer to as kek-lacZ, see Musacchio Drosophila EGFR:Kek1:WT baculovirus. For the domain deletion
experiment, cells were infected with a 10:20 ratio of EGFR:Kek1and Perrimon (1996). The two overlapping deficiencies, RA5 and
RM2, completely delete the kek1 gene (Musacchio and Perrimon, virus. For both experiments, cells were infected for 48 hr and then
lysed in 1 ml 20 mM HEPES/Na, 150 mM Nacl, 1mM EDTA, 1% NP-1996), and we refer to RA5/RM2 females as kek1 mutant females
in this paper. 40, 1 mM PMSF, and 1 mg/ml each of pepstatin A, aprotinin, and
leupeptin. Cleared lysates were immunoprecipitated with 1 mg anti-The alleles of the egfr, egfrQYI, egfrCJ, egfr101, egfr2E07 are described
in Clifford and Schupbach (1989). For a description of grkHK36, see Myc (Ab2, NeoMarkers). Precipitates were washed three times with
lysis buffer, resolved by 6% SDS-PAGE, and blotted with 1/5000Schupbach (1987) and Neuman-Silberberg and Schupbach (1993).
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anti-EGFR or 1/5000 anti-Torso. Filters were then stripped and re- Kharitonenkov, A., Chen, Z., Sures, I., Wang, H., Schilling, J., and
Ullrich, A. (1997). A family of proteins that inhibit signaling throughprobed with 1/200 anti-Myc.
tyrosine kinase receptors. Nature 386, 181±186.
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